title: Separation of clinical quantities of CD34+ cells from human marrow using immunomagnetic procedures.
authors.affiliation: Immunotherapy Division, Baxter Healthcare Corporation, Santa Ana, California.
authors.forename: J
authors.initials: J
authors.lastname: Burgess
authors.forename: C
authors.initials: C
authors.lastname: Traycoff
authors.forename: A
authors.initials: A
authors.lastname: Hardwick
authors.forename: A
authors.initials: A
authors.lastname: Smith
authors.forename: G
authors.initials: G
authors.lastname: Hangoc
authors.forename: L
authors.initials: L
authors.lastname: Ishizawa
authors.forename: M
authors.initials: M
authors.lastname: Moubayed
authors.forename: R
authors.initials: R
authors.lastname: Broun
authors.forename: E
authors.initials: E
authors.lastname: Srour
authors.forename: A
authors.initials: A
authors.lastname: Gee
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D018952:Antigens, CD34; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology*; D001854:Bone Marrow Cells; D003114:Colony-Forming Units Assay; D017077:Culture Media, Conditioned; D004921:Erythropoietin / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006801:Humans; D018189:Immunomagnetic Separation / Q000295:instrumentation / Q000379:methods*; D066298:In Vitro Techniques
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D017077:Culture Media, Conditioned; D004921:Erythropoietin